Article PDF
Avoid common mistakes on your manuscript.
References
Weir E, Fisman DN: Latent tuberculosis: revised treatment guidelines. CMAJ 169:937–938, 2003
Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection—New York and Georgia, 2000. Morb Mortal Wkly Rep 50:289–291, 2001
Jasmer RM, Saukkonen JJ, Blumberg HM, et al. : Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial. Ann Intern Med 137:640–647, 2002
MMWR Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for the treatment of latent infection—United States, 2003, Morb Mortal Wkly Rep, 52, 735–739, 2003
Lewis J, Zimmerman H: Drug-induced autoimmune liver disease. In Autoimmune Liver Diseases. Krawitt EL, Wiesner RH, Nishioka (eds). New York, Elsevier Science BV, 1998, pp 627–649
Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973
Rodman JS, Deutsch DJ, Gutman SI: Methyldopa hepatitis: A report of six cases and review of the literature. Am J Med 60:941–948, 1976
Arranto AJ, Sotaniemi WEA: Morphologic alteration in patients with α-methyldopa-induced liver damage after short and long term exposure. Scand J Gastroenterol 16:53, 1981
Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatitis necrosis associated with nitrofurantoin. Ann Intern Med 92:14–19, 1980
Selroos O, Edgren J: Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin: Report of three cases. Acta Med Scand 197:125–129, 1975
Lundgren R, Back O, Wiman LG: Pulmonary lesions and autoimmune reactions after long term nitrofurantoin treatment. Scand J Resp Dis 56:208–212, 1975
Hatoff DE, Cohen M, Schweigart DF, et al. : Nitrofurantoin: Another cause of drug-induced chronic active hepatitis?. A report of a patient with HLA-B8 antigen. Am J Med 67:117–121, 1979
Iwarson S, Lindberg J, Lunden P: Nitrofurantoin induced chronic liver disease: clinical course and outcome of five cases. Scand J Gastroenterol 14:497–502, 1979
Stricker BHCH, Blok APR, Claas FHJ, et al. : Hepatic injury associated with the use of nitrofurans: A clinical pathological study of 52 cases. Hepatology 8:599–606, 1988
Gough A, Chapman S, Wagstaff K, et al. : Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 312:169–172, 1996
Malcolm A, Heap TR, Eckstein RP, et al. : Minocycline induced liver injury. Am J Gastroenterol 91:1641–1643, 1996
Goldstein PE, Devier J, Cremer M: Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol 92:143–146, 1997
Bhat G, Jordan J Jr, Sokalski S, et al. : Minocycline-induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 27:74–75, 1998
Goldstein NS, Bayati N, Silverman AL, et al. : Minocycline as a cause of drug-induced autoimmune hepatitis: Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 114:591–598, 2000
Teitelbaum JE, Perez-Atayde AR, Cohen M, et al. : Minocycline-related autoimmune hepatitis: Case series and literature review. Arch Pediatr Adolesc Med 152:1132–1136, 1998
Abe M, Furukawa S, Takayama S, et al. : Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 42:48–52, 2003
Pariente EA, Hamoud A, Godfain D, et al. : Clometacin hepatitis. Retrospective study of 30 cases. A model of drug-induced autoimmune hepatitis?. Gastroenterol Clin Biol 13:769–774, 1989
Pessayre D, Degos F, Feldmann G, et al. : Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digestion 22:66–72, 1981
Al-Ashgar H, Al-Sohaibani F, Kagevi I, et al. : Autoimmune hepatitis induced by alpha-interferon therapy in a patient with chronic myeloid leukemia. Ann Saudi Med 22:73–74, 2002
Pittau E, Bogliolo A, Tinti A, et al. : Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C. Clin Exp Rheumatol 15:415–419, 1997
Sezaki H, Arase Y, Tsubota A, et al. : Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy. J Gastroenterol 38:493–500, 2003
Reynolds TB, Peters RL, Yamada S: Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285:813–820, 1971
Reynolds TB: Laxative liver disease. In Drugs and the Liver. Gerok W, Sickling K (eds). Stuttgart: FK Schattauer-Verlag, 1975 pp 319–325
Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973
Cooksley WGE, Cowen AE, Powell LW: The incidence of oxyphenisatin ingestion in active chronic hepatitis: A prospective controlled study of 29 patients. Aust NZ J Med 3:124–128, 1973
Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973
Farrell GC: Drug-Induced Liver Disease. Edinburgh, Churchill Livingstone, 1994
Scully LJ, Toze C, Sengar DP, et al. : Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 104:1478–1484, 1993
Huang MJ, Liaw YF: Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 10:344–350, 1995
Giannoccaro F, Pace L, Antonaci S, et al. : Autoimmune hemolytic anemia in chronic hepatitis C virus infectioin treated with alpha-interferon: A therapy-related event or extra-hepatic immunologic manifestation?. Recenti Prog Med 90:592–594, 1999
Pinol V, Cubiella J, Navasa M, et al. : Autoimmune hepatitis associated with thyroiditis and hypophysitis. A case report. Gastroenterol Hepatol 23:123–125, 2000
Ghilardi G, Gonvers JJ, So A: Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection. Br J Rheumatol 37:1349–1351, 1998
Zeniya M: Thyroid disease in autoimmune liver diseases. Nippon Rinsho 57:1882–1887, 1999
Cindoruk M, Yetkin I, Karakan T, et al. : The prevalence of autoimmune hepatitis in Hashimoto’s thyroiditis in a Turkish population. Acta Gastroenterol Belg 65:143–145, 2002
Nordyke RA, Gilbert F Jr, Miyamoto LA, et al. : The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto’s thyroiditis. Arch Intern Med 153:862–865, 1993
Poncin E, Silvain C, Touchard G, et al. : Papaverine-induced chronic liver disease. Gastroenterology 90:1051–1053, 1986
Poupon R, Longchal C, Darnis F: Hepatite chronique associee a la prise prolongee de papaverine. Gastroenterol Clin Biol 2:305–309, 1978
Chousterman M, Pulik M, Perie G: Hepatite a la papaverine. Nouv Presse Med 9:1899, 1980
Desechalliers JP, Lerebours E, Tilly H, et al. : Hepatite chronique compliquee de cirrhose, due a la papaverine. Gastroenterol Clin Biol 5:818, 1981
Pelli N, Setti M, Ceppa P, et al. : Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol 15:921–924, 2003
Graziadei IW, Obermoser GE, Sepp NT, et al. : Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12:409–412, 2003
Ben-Yahia M, Mavier P, Metreau JM, et al. : Chronic active hepatitis and cirrhosis induced by wild germander: Three cases. Gastroenterol Clin Biol 17:959–962, 1993
Larrey D, Vial T, Pauurels A, et al. : Hepatitis after germander (Teucrium Chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 117:129–132, 1992
Maddrey WC, Boitnott JK: Drug-induced chronic active hepatitis. In Autoimmune Liver Disease. Krawitt EL, Wiesner RH (eds). New York, Raven Press, 1991 pp 191–232
Stricker BHCh: Drug-Induced Hepatic INjury. Amsterdam, Elsevier, 1992
Maggiore G, Larizza D, Lorini R, et al. : Propylthiouracil hepatotoxicity mimicking autoimmune chronic hepatitis in a girl. J Pediatr Gastroenterol 8:547–548, 1989
Cui B, Abe M, Hidata S, et al. : Autoimmune hepatitis associated with Graves’ disease. Intern Med 42:331–355, 2003
Scully LJ, Clarke D, Barr RJ: Diclofenac-induced hepatitis in three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 38:744–751, 1993
Banks AT, Zimmerman HJ, Ishak KG, et al. : Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22:820–827, 1995
Sterling MJ, Kane M, Grace ND: Pemoline induced autoimmune hepatitis. Am J Gastroenterol 91:2233–2234, 1996
Selimoglu MA, Ertekin V: Autoimmune hepatitis triggered by Brucella infection or doxycycline or both. Int J Clin Pract 57:639–641, 2003
Babany G, Larrey D, Pessayre D, et al. : Chronic active hepatitis caused by benzarone. J Hepatol 5:332–335, 1987
Bernard PH, Lamouliatte H, Le Bail B: Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate. Gastroenterol Clin Biol 18:1048, 1994
Kamiyama T, Nouchi T, Kojima S, et al. : Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 92:703–704, 1997
Murakami M, Kakizaki S, Takayama H, et al. : Autoimmune thyroid disease induced by interferon therapy. Nippon Rinsho 57:1779–1783, 1999
Ward DL, Bing-You RG: Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: Screening and monitoring recommendations. Endocr Pract 7:52–58, 2001
Dusheiko G: Side effects of alpha interferon in chronic hepatitis C. Hepatology 26:112–21S, 1997
Mekkakia-Benhabib C, Marcellin P, Colas-Linhart N, et al. : Natural history of dysthyroidism during interferoin treatment of chronic hepatitis C. Ann Endocrinol (Paris) 57:419–427, 1996
Garcia FG, Marco MA, Vela J, et al. : Hypothyroidism as a complication of the treatment of hepatitis C with interferon. Ann Intern Med 13:438–440, 1996
Martin-Vivaldi R, Nogueras F, Quintero D, et al. : Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment. with interferon. Rev Esp Enferm Dig 88:480–484, 1996
Rocco A, Gargano S, Provenzano A, et al. : Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection. Neuroendocrinol Lett 22:39–44, 2001
Broussolle C, Steineur MP, Bailly F, et al. : Hepatitis C virus infection and thyroid diseases. Rev Med Int 20:766–773, 1999
Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. : Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 44:635–642, 1999
Maccari S, Bassi C, Giovannini AG, et al. : A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 10:452–454, 1991
Martocchia A, Labbadia G, Paoletti V, et al. : Hashimoto’s disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease. Neuroendocrinol Lett 22:49–52, 2001
Yoshikawa M, Sakamoto T, Mitoro A, et al. : Autoimmunity during alpha-interferon therapy for chronic hepatitis C. Gastroenterol Jpn 28:109–114, 1993
Okanoue T, Sakamoto S, Itoh Y, et al. : Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283–291, 1996
Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. : Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158:1445–1448, 1998
D’Hondt L, Delannoy A, Docqueir C: Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 12:415–417, 1993
Morisco F, Mazziotti G, Rotondi M, et al. : Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. Dig Liver Dis 33:247–253, 2001
Shimizu M, Hirokawa M, Manabe T, et al. : Lithium associated autoimmune thyroiditis. J Clin Pathol 50:172–174, 1997
Gudbjornsson B, Kristinsson A, Geirsson G, et al. : Painful autoimmune thyroiditis occurring on amiadarone therapy. Acta Med Scand 221:219–220, 1987
Nishiyama S, Matsukura M, Fujimoto S, et al. : Reports of two cases of autoimmune thyroiditis while receiving anticonvulsant therapy. Eur J Pediatr 140:116–117, 1983
Takorabet L, Ropars A, Stasiuk L, et al. : Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: A pathophysiological mechanism for drug-induced autoimmunity?. Clin Exp Immunol 111:415–421, 1998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khokhar, O., Gange, C., Clement, S. et al. Autoimmune Hepatitis and Thyroiditis Associated with Rifampin and Pyrazinamide Prophylaxis: An Unusual Reaction. Dig Dis Sci 50, 207–211 (2005). https://doi.org/10.1007/s10620-005-1302-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-1302-0